Apollomics (APLM) Shares Outstanding (2020 - 2025)

Apollomics (APLM) posted quarterly Shares Outstanding (Entity) of $144.6 million for Q4 2025, up 41.76% year-on-year from $102.0 million in Q4 2024, and down 99.87% on a QoQ basis from $110.3 billion in Q2 2025.

Apollomics (APLM) Shares Outstanding (2020 - 2025) Analysis & Trends

Apollomics (APLM) has reported Shares Outstanding (Entity) for 6 consecutive years, with $144.6 million the latest figure, recorded in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 41.76% year-over-year to $144.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $144.6 million (up 41.76% YoY) and the FY2025 annual result came in at $144.6 million, up 41.76% from the prior year.
  • Shares Outstanding (Entity) slipped to $144.6 million in Q4 2025 per APLM's latest filing, from $110.3 billion in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for APLM reached as high as $110.3 billion in Q2 2025 and fell as low as $3.9 million in Q2 2022.
  • A 5-year average of $12.3 billion and a median of $54.5 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) sank 80.97% — and 2025, when it jumped 843374.67%.
  • Year by year, Shares Outstanding (Entity) stood at $56.4 million in 2021, then retreated by 3.28% to $54.5 million in 2022, then plunged by 80.97% to $10.4 million in 2023, then surged by 882.55% to $102.0 million in 2024, then surged by 41.76% to $144.6 million in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $144.6 million, $110.3 billion, and $102.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6,012.74 Bn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 47.82 Bn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.44 Bn
4 NuCana 279.75 Bn 279.75 Bn - 11.23 Bn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 400.00 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Apollomics 2.66 Bn 2.66 Bn - 1.45 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.45 Mn
Jun 30, 2025 1.10 Bn
Dec 31, 2024 1.02 Mn
Jun 30, 2024 937,400.00
Dec 31, 2023 744,110.00
Jun 30, 2023 590,000.00
Dec 31, 2022 3.91 Mn
Jun 30, 2022 279,820.00
Dec 31, 2021 4.04 Mn
Dec 31, 2020 3.61 Mn